(720 ILCS 570/207) (from Ch. 56 1/2, par. 1207)
    Sec. 207. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule III if it finds that:
        (1) the substance has a potential for abuse less than
the substances listed in Schedule I and II;
        (2) the substance has currently accepted medical use
in treatment in the United States; and
        (3) abuse of the substance may lead to moderate or
low physiological dependence or high psychological dependence.
(Source: P.A. 97-334, eff. 1-1-12.)